AR
Antony A Riley
Chief Financial Officer

Antony A Riley insider trades: Forte Biosciences (FBRX) stock buys and sales

Chief Financial Officer, Forte Biosciences Last trade Dec 30, 2025 40 Form 4 filings
$0
Sold, last 12 months
0 sales
$255K
Bought, last 12 months
1 buy
7
Open-market trades
since 2006
3
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Antony reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 30, 2025FBRX↑ Buy$255K
Nov 21, 2024FBRX↑ Buy$125K
Sep 7, 2021FBRX↓ Sell$106K
Jun 29, 2020FBRX↑ Buy$96K
May 22, 2018KRYS↑ Buy$30K
Oct 2, 2006AVNX↓ Sell$47K
May 11, 2006AVNX↓ Sell$32K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Antony A Riley's insider trades

Antony A Riley is Chief Financial Officer at Forte Biosciences (FBRX). Since May 11, 2006, Antony has reported 4 open-market purchases worth $506K and 3 sales worth $185K on SEC Form 4. In the last 12 months: 1 buy ($255K).

Their filings also include option exercises (20 filings), grants and awards (16 filings), shares withheld for taxes (15 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FBRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.